Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.

Clin Cancer Res. 2000 Apr;6(4):1351-64. Unique Identifier : AIDSLINE MED/20239234
Saito T; Dworacki G; Gooding W; Lotze MT; Whiteside TL; University of Pittsburgh Cancer Institute, University of; Pittsburgh School of Medicine, Pennsylvania 15213, USA.


Abstract: Peripheral blood mononuclear cells (PBMCs) obtained from patients with advanced melanoma but not from healthy individuals were found to undergo spontaneous ex vivo apoptosis upon incubation in medium. PBMCs were evaluated for evidence of apoptosis using Annexin V binding, caspase-3 activation, and DNA fragmentation (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling). PBMCs of patients with melanoma contained a significantly higher proportion (P = 0.0027) of spontaneously apoptotic cells than PBMCs of controls after 24-h incubation in medium alone. The relative proportion of activated Fas+ and tumor necrosis factor receptor 1-positive (TNFR1+) PBMCs was significantly higher in patients with melanoma than that observed in controls. To demonstrate that the TNF family of receptors and ligands was involved in this type of apoptosis, PBMCs were incubated in the presence of agonistic anti-Fas antibody (CH-11) or TNF-alpha. The proportion of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive PBMCs undergoing spontaneous apoptosis was found to be comparable with that induced by CH-11 antibody or TNF-alpha. Three-color flow cytometry revealed that CD3+ Fas+ T cells were especially sensitive to apoptosis and were preprogrammed in vivo to die. Apoptosis occurred in all subsets of PBMCs but was significantly higher (P = 0.01) in the CD3+ CD8+ T-cell subset in patients relative to controls. In two patients with melanoma, who responded clinically to dendritic cell-based peptide vaccines, the proportion of apoptotic T cells was decreased by half after therapy. In patients who were treated previously with vaccination-based therapies, levels of T-cell apoptosis were lower than in the other melanoma patients. The observed accelerated death of T cells, which are activated and susceptible to apoptosis in patients with melanoma, may contribute to a rapid turnover of immune cells, resulting in a decreased immunocompetence.
Keywords: JOURNAL ARTICLE Adult Aged Annexin V/METABOLISM Antigens, CD/ANALYSIS Antigens, CD14/ANALYSIS Antigens, CD19/ANALYSIS Antigens, CD3/ANALYSIS Antigens, CD4/ANALYSIS Antigens, CD56/ANALYSIS Antigens, CD8/ANALYSIS Antigens, CD95/ANALYSIS *Apoptosis Caspases/METABOLISM Cohort Studies CD8-Positive T-Lymphocytes/*CYTOLOGY/IMMUNOLOGY/METABOLISM DNA Fragmentation Female Flow Cytometry Human In Situ Nick-End Labeling Leukocytes, Mononuclear/CYTOLOGY/IMMUNOLOGY/METABOLISM Male Melanoma/IMMUNOLOGY/METABOLISM/*PATHOLOGY Middle Age Protein Binding Receptors, IgG/ANALYSIS Receptors, Tumor Necrosis Factor/ANALYSIS Support, U.S. Gov't, P.H.S.KWDjournalarticleadultagedannexinv/metabolismantigens,cd/analysisantigens,cd14/analysisantigens,cd19/analysisantigens,cd3/analysisantigens,cd4/analysisantigens,cd56/analysisantigens,cd8/analysisantigens,cd95/analysisKWDapoptosiscaspases/metabolismcohortstudiescd8-positivet-lymphocytes/KWDcytology/immunology/metabolismdnafragmentationfemaleflowcytometryhumaninsitunick-endlabelingleukocytes,mononuclear/cytology/immunology/metabolismmalemelanoma/immunology/metabolism/KWDpathologymiddleageproteinbindingreceptors,igg/analysisreceptors,tumornecrosisfactor/analysissupport,uKWDsKWDgov't,pKWDhKWDs
001030
A00A1078

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .